Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AGNon-nucleoside reverse transcriptase inh
- Chemical substanceJ05AG01Nevirapine
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 22 medicines
- Nevirapine100MG, 400MG · tablet, extended release · Apotex
- Nevirapine200MG · tablet · Ranbaxy
- Nevirapine50MG/5ML · suspension · Aurobindo
- Viramune50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · suspension · Boehringer Ingelheim
Spain
AEMPS · 14 medicines



